Switching to Insulin Degludec improves glycemic control in patients with type 2 diabetes (T2dm) in a real-world setting. Results of the EU-TREAT study from six European countries with special emphasis on the Austrian sub-cohort
- S Pusarnig (Autor*in)
- L Stechemesser (Autor*in)
- A Vonbank (Autor*in)
- R Weitgasser (Autor*in)
- HR Schonherr (Autor*in)
- Sourij, H. (Autor*in)
- CK Tikkanen (Autor*in)
- A Brugger (Autor*in)
- R Prager (Autor*in)
Aktivität: Vortrag oder Poster › Poster